Tom Reilly

Tom Reilly joined Amarin in June 2022 as the Company’s Chief Financial Officer. He has more than 20 years of experience in building and leading finance and administration teams at life sciences companies both in the United States and globally. Most recently Mr. Reilly served as Chief Financial Officer for Cara Therapeutics, where he was responsible for leading all aspects of the Company’s financial operations and planning. Prior to Cara Therapeutics, he served as Head of Finance of the Allergan General Medicines business. Prior to joining Allergan, Mr. Reilly spent 14 years with Novartis where he served in roles of increasing responsibility, including Finance Head for the Company’s Oncology Development unit, CFO for Novartis Pharma Austria and Financial Controller for Novartis USA’s Pharmaceutical Division. He earned his bachelor’s degree in finance from Manhattan College, an M.B.A in accounting from Seton Hall University and is a certified public accountant.